AUXL : Analysis & Opinions

  1. Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst ...

    January 22, 2015
    Endo International has priced $1.2 billion aggregate principal amount of 6.00% senior notes due Feb 2025 at par with a face ...
  2. OncoMed Starts Expansion Stage Study for Solid Tumor Drug - Analyst ...

    January 16, 2015
    OncoMed Pharmaceuticals, Inc. (OMED) has enrolled the first biomarker-selected patient in the expansion stage of a phase ...
  3. BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst ...

    January 15, 2015
    BioCryst Pharmaceuticals, Inc. (BCRX) received a positive opinion regarding its application for orphan drug status for BCX4161 ...
  4. 4 Biotech Stocks that Doubled in 2014 - Analyst Blog

    December 26, 2014
    Promising pipeline candidates, progress on the regulatory front and interesting research platforms helped these 4 biotech ...
  5. Endo/BioDelivery File Regulatory Application for Pain Drug - ...

    December 24, 2014
    Endo International along with its partner BioDelivery Sciences International, Inc. announced the submission of a new drug ...
  6. Auxilium's Xiapex Gets CHMP Nod for Peyronie's Disease - Analyst ...

    December 23, 2014
    Auxilium Pharmaceuticals (AUXL) and partner Sobi's Xiapex is a step closer to EU approval with the CHMP giving a favorable ...
  7. 4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst ...

    December 16, 2014
    Despite the sell-off in late March, the biotech sector bounced back thanks to important product approvals, mergers and acquisitions, ...
  8. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  9. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  10. Healthcare Stocks, Including Pharmacyclics, Making Big Moves ...

    December 17, 2012
    On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up 0.5%. ...
  11. Biggest Healthcare Sector Movers, Including SHPG

    July 31, 2012
    After the morning's trading, the Nasdaq is trading up 0.4%, the S&P 500 remains relatively unchanged and the Dow is unchanged. ...
  12. 3 Stocks Ripe for Upside Reversals

    July 23, 2011
    Sentiment seems to be turning more favorable toward these three stocks, and given new insider buying, shares may be ready ...
Trading Center